Clinical Trial Update: A First-in-Human Study of PRL3-ZUMAB [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study evaluating PRL3-ZUMAB in patients with advanced solid tumors. The trial is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PRL3-ZUMAB

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Advanced Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING